Annals of Oncology
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Annals of Oncology
Jun 23, 2024, 14:32 |
Blog
Impact of Hormone Receptor Status and Tumor Subtypes of Breast Cancer in Young BRCA Carriers
Matteo Lambertini shared a post by Annals of Oncology, on X: "Presented at ASCO24 by Luca Arecco and…
Jun 22, 2024, 14:12 |
Insight
New Paper Alert! Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures
Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures Authors: Nicolas Fraunhoffer,…
Jun 19, 2024, 12:19 |
Blog
Oncology Advance - See this month’s highlights from the ESMO portfolio
Oncology Advance shared a post on X: "See this month’s highlights from the ESMO portfolio. Featured…
Jun 15, 2024, 07:36 |
Blog
Tom Powles and Giorgio Bogani Discuss the Recently Published Study on Advanced or Recurrent Endometrical Cancer
The European Society for Medical Oncology (ESMO) posted on LinkedIn: “Latest podcast Annals of Oncology Editor-in-Chief…
Jun 12, 2024, 01:33 |
Insight
Upfront resection versus no resection of the primary tumor in patients with synchronous mCRC - Julius Center Research Program Cancer
Julius Center Research Program Cancer shared a post on LinkedIn: …
Jun 10, 2024, 11:27 |
Insight
Arndt Vogel on a paper by D.E.W. van der Kruijssen et al.
Arndt Vogel shared a post on X: "Upfront resection vs no resection of the primary…
Jun 10, 2024, 10:31 |
Opinion
Armando Orlandi: To explain the unexplainable in MONARCH 3
Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, made the following post on X:…
Jun 7, 2024, 09:11 |
Insight
Erika Hamilton: Happy to share the publication in Annals of Oncology
Erika Hamilton shared a post on X: “Happy to share the publication in Annals of…
May 24, 2024, 13:24 |
Insight
Erman Akkus Summarizes 5-year Results of CheckMate 040
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: “Nivolumab plus ipilimumab…
May 24, 2024, 11:17 |
Insight
Piotr Wysocki: Patients with hypermutated colorectal cancer (POLE/D1pd) derive profound benefit from immunotherapy
Piotr Wysocki recently posted on LinkedIn: "Ambrosini N et al. published online (Annals of Oncology) the…
1
2
3
4
All:
31
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube